Rona Smith

3.1k total citations
63 papers, 1.7k citations indexed

About

Rona Smith is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Rona Smith has authored 63 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 33 papers in Rheumatology and 21 papers in Genetics. Recurrent topics in Rona Smith's work include Vasculitis and related conditions (46 papers), Otitis Media and Relapsing Polychondritis (21 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (18 papers). Rona Smith is often cited by papers focused on Vasculitis and related conditions (46 papers), Otitis Media and Relapsing Polychondritis (21 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (18 papers). Rona Smith collaborates with scholars based in United Kingdom, United States and Sweden. Rona Smith's co-authors include David Jayne, Rachel Jones, Federico Alberici, Afzal Chaudhry, Stella Burns, Darren M. Roberts, Kenneth G. C. Smith, Aladdin J Mohammad, Mary‐Jane Guerry and Peter A. Merkel and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of the American Society of Nephrology.

In The Last Decade

Rona Smith

58 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rona Smith United Kingdom 21 1.2k 721 563 415 393 63 1.7k
Peter Hewins United Kingdom 17 692 0.6× 267 0.4× 231 0.4× 369 0.9× 139 0.4× 37 1.1k
Simone Baldovino Italy 24 320 0.3× 654 0.9× 226 0.4× 267 0.6× 98 0.2× 73 1.5k
Ruth J. Pepper United Kingdom 18 366 0.3× 609 0.8× 148 0.3× 399 1.0× 89 0.2× 44 1.1k
R. Pérez-Álvarez Spain 19 488 0.4× 599 0.8× 99 0.2× 302 0.7× 640 1.6× 25 1.6k
Cándido Díaz‐Lagares Spain 19 277 0.2× 704 1.0× 101 0.2× 357 0.9× 420 1.1× 25 1.5k
Lillian Barra Canada 18 373 0.3× 658 0.9× 99 0.2× 322 0.8× 127 0.3× 53 1.2k
Per Bygren Sweden 20 723 0.6× 255 0.4× 317 0.6× 228 0.5× 225 0.6× 35 1.2k
Carla Naretto Italy 19 312 0.3× 398 0.6× 198 0.4× 172 0.4× 68 0.2× 38 989
Jean‐François Viallard France 11 447 0.4× 544 0.8× 103 0.2× 302 0.7× 210 0.5× 18 1.0k
Maria Letizia Urban Italy 21 348 0.3× 611 0.8× 88 0.2× 224 0.5× 75 0.2× 53 1.1k

Countries citing papers authored by Rona Smith

Since Specialization
Citations

This map shows the geographic impact of Rona Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rona Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rona Smith more than expected).

Fields of papers citing papers by Rona Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rona Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rona Smith. The network helps show where Rona Smith may publish in the future.

Co-authorship network of co-authors of Rona Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Rona Smith. A scholar is included among the top collaborators of Rona Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rona Smith. Rona Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prieto‐González, Sergio, et al.. (2025). ANCA-associated vasculitis and interstitial lung disease: challenges and open questions. European Journal of Internal Medicine. 143. 106553–106553. 1 indexed citations
2.
Trivioli, Giorgio, Marta Casal Moura, Andreas Kronbichler, et al.. (2025). Advances in the treatment of ANCA-associated vasculitis. Nature Reviews Rheumatology. 21(7). 396–413. 2 indexed citations
3.
Smith, Rona & Bernhard Hellmich. (2025). Highlights from the plenary session: advances in treatment (I). Lara D. Veeken. 64(Supplement_1). i88–i91.
4.
Stacey, Hannah D., Lucy Francis, Rona Smith, & Rachel Jones. (2024). Practical Management of ANCA-Associated Vasculitis: A Clinician’s Perspective. SHILAP Revista de lepidopterología. 5(1). 84–102. 2 indexed citations
5.
Floßmann, Oliver, Rachel Jones, Thomas Simpson, et al.. (2024). Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage. Nephrology Dialysis Transplantation. 39(9). 1473–1482. 13 indexed citations
6.
Oni, Louise, et al.. (2024). Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research. Journal of the American Society of Nephrology. 35(4). 502–504. 1 indexed citations
7.
Jones, Rachel, et al.. (2024). Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis. Clinical Kidney Journal. 18(1). sfae379–sfae379. 1 indexed citations
8.
Dosanjh, Davinder, Thomas F. Hiemstra, Alex Richter, et al.. (2023). PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V). Trials. 24(1). 185–185. 3 indexed citations
9.
Kronbichler, Andreas, et al.. (2023). Using a Network-Based Analysis Approach to Investigate the Involvement of S. aureus in the Pathogenesis of Granulomatosis with Polyangiitis. International Journal of Molecular Sciences. 24(3). 1822–1822. 1 indexed citations
10.
Devonshire, Ginny, Ahmad Miremadi, Liang Zhuang, et al.. (2023). SO-12 CLDN18.2 expression in resectable gastroesophageal cancers: Associated clinical and molecular signatures and impact of neoadjuvant chemotherapy on intratumor heterogeneity. Annals of Oncology. 34. S166–S167. 1 indexed citations
11.
Odler, Balazs, Regina Riedl, Philipp Gauckler, et al.. (2023). Risk factors for serious infections in ANCA-associated vasculitis. Annals of the Rheumatic Diseases. 82(5). 681–687. 31 indexed citations
12.
Weiss, Anne, James Goodman, Marie Fisk, et al.. (2022). Niclosamide—A promising treatment for COVID‐19. British Journal of Pharmacology. 179(13). 3250–3267. 61 indexed citations
13.
Gopaluni, Seerapani, Rona Smith, Elizabeth Wallin, et al.. (2022). Alemtuzumab for refractory primary systemic vasculitis—a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE). Arthritis Research & Therapy. 24(1). 81–81. 14 indexed citations
14.
Smith, Rona, Daniel J Cooper, Rainer Döffinger, et al.. (2022). SARS-COV-2 vaccine responses in renal patient populations. BMC Nephrology. 23(1). 199–199. 4 indexed citations
15.
Egan, Allyson, Rona Smith, & David Jayne. (2021). Introduction to the European Vasculitis Society 3rd International Vasculitis Course (Cambridge) case-based supplement. Lara D. Veeken. 60(Supplement_3). iii1–iii5.
16.
Smith, Rona, et al.. (2021). Cardiac decompensation revealing giant cell arteritis. Lara D. Veeken. 60(Supplement_3). iii9–iii11.
17.
Kronbichler, Andreas, Julia Kerschbaum, Seerapani Gopaluni, et al.. (2018). Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis. Annals of the Rheumatic Diseases. 77(10). 1440–1447. 89 indexed citations
18.
Smith, Rona, Rachel Jones, Mary‐Jane Guerry, et al.. (2012). Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis & Rheumatism. 64(11). 3760–3769. 176 indexed citations
19.
Smith, Rona, Rachel Jones, & David Jayne. (2012). Progress in treatment of ANCA-associated vasculitis. Arthritis Research & Therapy. 14(2). 210–210. 41 indexed citations
20.
Smith, Rona, Menna R. Clatworthy, & David Jayne. (2010). Biological therapy for lupus nephritis—tribulations and trials. Nature Reviews Rheumatology. 6(9). 547–552. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Hewins Breakdown of academic impact, for papers by Simone Baldovino Breakdown of academic impact, for papers by Ruth J. Pepper Breakdown of academic impact, for papers by R. Pérez-Álvarez Breakdown of academic impact, for papers by Cándido Díaz‐Lagares Breakdown of academic impact, for papers by Lillian Barra Breakdown of academic impact, for papers by Per Bygren Breakdown of academic impact, for papers by Carla Naretto Breakdown of academic impact, for papers by Jean‐François Viallard Breakdown of academic impact, for papers by Maria Letizia Urban
Rankless by CCL
2026